跳至主要内容
临床试验/ISRCTN12590098
ISRCTN12590098进行中(未招募)3 期

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised, double-blind, placebo-controlled trial

ondon School of Hygiene & Tropical Medicine0 个研究点目标入组 30,000 人开始时间: 2023年1月20日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
30,000

研究概览

简要总结

2023 Protocol article in https://doi.org/10.1186/s13063-023-07687-1 (added 04/12/2023)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women thought to be aged 18 years and over admitted to the hospital for a vaginal or caesarean birth
  • 2. One or more known risk factors for PPH

排除标准

  • The fundamental eligibility criterion is the responsible doctor’s ‘uncertainty’ about whether to use tranexamic acid in a particular woman. Women should not be randomised if the responsible doctor believes that tranexamic acid is clearly indicated (e.g., tranexamic acid has been given within 12 hours or planned to be given) or clearly contraindicated (e.g., known allergy to tranexamic acid).

研究者

发起方
ondon School of Hygiene & Tropical Medicine

相似试验